Innovative Research Collaborations in Times of Uncertain Funding

The conference focused on new partnerships and trends created in the face of changing investment in clinical and translational research. Experts representing academia, industry, foundations, investors and government described current models and innovative trends shaping the future. The conference was held at the Emory Conference Center (Lullwater Ballroom), starting at 11:30 a.m.

AGENDA

11:30 a.m.-12:30 p.m. Registration Opens / Networking / Lunch
Emory Conference Center Dining Room

12:30-12:40 p.m. Introduction

C. Russell Allen, President and CEO, Georgia Bio
David S. Stephens, MD Principal Investigator, Atlanta Clinical & Translational Science Institute and Vice President for Research, Robert W. Woodruff Health Sciences Center, Emory University

12:40-1:40 p.m. DRIVE: An Innovative, Non-Profit Drug Development Company

Keynote Speaker: Dennis C. Liotta, PhD, Samuel Dobbs Candler Professor of Chemistry, Emory University; Executive Director, Emory Institute for Drug Development; and Editor-in-Chief, ACS Medicinal Chemistry Letters

1:40-2:20 p.m. Academic Industry Research Relationships Across the Continuum of Technology Development 
Jilda Garton, Vice President for Research, Georgia Institute of Technology; General Manager, Georgia Tech Research Corporation and Georgia Tech Applied Research Corporation; and Immediate Past President of the University-Industry Demonstration Partnership Board

2:20-2:50 p.m. Break

2:50-3:20 p.m. The Grand Experiment: Translating University Innovations
Elias Caro, Vice President, Technology Development, Wallace H. Coulter Foundation

3:20-3:50 p.m. State & Federal Perspective
New Policy Directive on SBIR/STTR Awards  – Julie Collins, Director of SBIR Program, Advanced Technology Development Center, Georgia Institute of Technology

GRA VentureLab, Current Status and Future Prospects  – Lee Herron, DVM, Vice President of Commercialization, Georgia Research Alliance

3:50-4:20 p.m. Break

4:20-5:00 p.m. Partnering with and Leveraging Academic Centers in the Conduct of Clinical Trials
Jonathan Zung, PhD, Vice President, Global Development Operations, Bristol Myers-Squibb

5:00-5:30 p.m. Venture Capital – 2013 Update
John Richard, MBA, Partner, Georgia Venture Partners; Senior Venture Partner, Phase4 Ventures; and Senior Business Advisor, Albireo AB